Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1965 May 1;92(18):962–969.

Ovarian Failure and the Menopause

Donald C McEwen
PMCID: PMC1928022  PMID: 14289145

Abstract

Long-term replacement therapy for ovarian deficiency or failure, including the menopause, has been widely debated. In the past, treatment, if indicated, was reassurance, sedation, and occasionally short-term estrogen therapy. Today, because of recent advances in steroid synthesis, the consequences of ovarian deficiency may be preventable.

Ovarian function and failure are discussed, the apparent physiological renaissance of nine patients documented, and the methods of treatment detailed. Thirty-three patients, who took part in this program during the past two years, have continued treatment with enthusiasm, without major problems in management, and have shown evidence of improved physical and emotional well-being.

Further unbiased long-term research, possibly using modern computer technique, is needed to decide between traditional and replacement therapy for the menopause.

Full text

PDF
962

Images in this article

963Fig. 1
on p.963

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON H. E. Clinical use of estrogen in uterine prolapse. J Am Med Assoc. 1958 Sep 13;168(2):173–174. doi: 10.1001/jama.1958.63000020001007. [DOI] [PubMed] [Google Scholar]
  2. BAKKE J. L. A TEACHING DEVICE TO ASSIST ACTIVE THERAPEUTIC INTERVENTION IN THE MENOPAUSE. West J Surg Obstet Gynecol. 1963 Nov-Dec;71:241–245. [PubMed] [Google Scholar]
  3. CARTER W. F., FAUCHER G. L., GREENBLATT R. B. EVALUATION OF A NEW PROGESTATIONAL AGENT, 6,17 ALPHA-DIMETHYL-6-DEHYDROPROGESTERONE. Am J Obstet Gynecol. 1964 Jul 1;89:635–641. doi: 10.1016/0002-9378(64)90158-9. [DOI] [PubMed] [Google Scholar]
  4. DORAN T. A., HARKINS J. L., GORNALL A. G., THOMPSON D. W. CLINICAL AND LABORATORY ASSESSMENT OF A NEW PROGESTATIONAL AGENT. Can Med Assoc J. 1964 Oct 24;91:900–907. [PMC free article] [PubMed] [Google Scholar]
  5. DUTTON W. A. PSYCHOLOGICAL FACTORS IN 155 PATIENTS WITH FUNCTIONAL UTERINE BLEEDING. Can Med Assoc J. 1965 Feb 20;92:398–405. [PMC free article] [PubMed] [Google Scholar]
  6. GRAHAM T. C., GREENBLATT R. B., BYRD J. R. GONADAL DYSGENESIS WITH AN XY CHROMOSOMAL CONSTITUTION. Obstet Gynecol. 1964 Nov;24:701–706. [PubMed] [Google Scholar]
  7. KINCH R. A., PLUNKETT E. R., SMOUT M. S., CARR D. H. PRIMARY OVARIAN FAILURE; A CLINICOPATHOLOGICAL AND CYTOGENETIC STUDY. Am J Obstet Gynecol. 1965 Mar 1;91:630–644. [PubMed] [Google Scholar]
  8. WALLACH S., HENNEMAN P. H. Prolonged estrogen therapy in postmenopausal women. J Am Med Assoc. 1959 Nov 21;171:1637–1642. [PubMed] [Google Scholar]
  9. WHITE A. E., MOORE F. J., MARMORSTON J. Prognostic features of acute myocardial infarction in men. A one-year study at the Los Angeles County Hospital. Arch Intern Med. 1960 Jun;105:859–865. doi: 10.1001/archinte.1960.00270180037005. [DOI] [PubMed] [Google Scholar]
  10. WILSON R. A. THE OBSOLETE MENOPAUSE. Conn Med. 1963 Dec;27:735–736. [PubMed] [Google Scholar]
  11. Wilson R. A., Brevetti R. E., Wilson T. A. Specific procedures for the elimination of the menopause. West J Surg Obstet Gynecol. 1963 Jan-Feb;71(1):110–121. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES